Cargando…

A new method for the high-precision assessment of tumor changes in response to treatment

MOTIVATION: Imaging demonstrates that preclinical and human tumors are heterogeneous, i.e. a single tumor can exhibit multiple regions that behave differently during both development and also in response to treatment. The large variations observed in control group, tumors can obscure detection of si...

Descripción completa

Detalles Bibliográficos
Autores principales: Tar, P D, Thacker, N A, Babur, M, Watson, Y, Cheung, S, Little, R A, Gieling, R G, Williams, K J, O’Connor, J P B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061877/
https://www.ncbi.nlm.nih.gov/pubmed/29547950
http://dx.doi.org/10.1093/bioinformatics/bty115
_version_ 1783342307328655360
author Tar, P D
Thacker, N A
Babur, M
Watson, Y
Cheung, S
Little, R A
Gieling, R G
Williams, K J
O’Connor, J P B
author_facet Tar, P D
Thacker, N A
Babur, M
Watson, Y
Cheung, S
Little, R A
Gieling, R G
Williams, K J
O’Connor, J P B
author_sort Tar, P D
collection PubMed
description MOTIVATION: Imaging demonstrates that preclinical and human tumors are heterogeneous, i.e. a single tumor can exhibit multiple regions that behave differently during both development and also in response to treatment. The large variations observed in control group, tumors can obscure detection of significant therapeutic effects due to the ambiguity in attributing causes of change. This can hinder development of effective therapies due to limitations in experimental design rather than due to therapeutic failure. An improved method to model biological variation and heterogeneity in imaging signals is described. Specifically, linear Poisson modeling (LPM) evaluates changes in apparent diffusion co-efficient between baseline and 72 h after radiotherapy, in two xenograft models of colorectal cancer. The statistical significance of measured changes is compared to those attainable using a conventional t-test analysis on basic apparent diffusion co-efficient distribution parameters. RESULTS: When LPMs were applied to treated tumors, the LPMs detected highly significant changes. The analyses were significant for all tumors, equating to a gain in power of 4-fold (i.e. equivalent to having a sample size 16 times larger), compared with the conventional approach. In contrast, highly significant changes are only detected at a cohort level using t-tests, restricting their potential use within personalized medicine and increasing the number of animals required during testing. Furthermore, LPM enabled the relative volumes of responding and non-responding tissue to be estimated for each xenograft model. Leave-one-out analysis of the treated xenografts provided quality control and identified potential outliers, raising confidence in LPM data at clinically relevant sample sizes. AVAILABILITY AND IMPLEMENTATION: TINA Vision open source software is available from www.tina-vision.net. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
format Online
Article
Text
id pubmed-6061877
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-60618772018-08-07 A new method for the high-precision assessment of tumor changes in response to treatment Tar, P D Thacker, N A Babur, M Watson, Y Cheung, S Little, R A Gieling, R G Williams, K J O’Connor, J P B Bioinformatics Original Papers MOTIVATION: Imaging demonstrates that preclinical and human tumors are heterogeneous, i.e. a single tumor can exhibit multiple regions that behave differently during both development and also in response to treatment. The large variations observed in control group, tumors can obscure detection of significant therapeutic effects due to the ambiguity in attributing causes of change. This can hinder development of effective therapies due to limitations in experimental design rather than due to therapeutic failure. An improved method to model biological variation and heterogeneity in imaging signals is described. Specifically, linear Poisson modeling (LPM) evaluates changes in apparent diffusion co-efficient between baseline and 72 h after radiotherapy, in two xenograft models of colorectal cancer. The statistical significance of measured changes is compared to those attainable using a conventional t-test analysis on basic apparent diffusion co-efficient distribution parameters. RESULTS: When LPMs were applied to treated tumors, the LPMs detected highly significant changes. The analyses were significant for all tumors, equating to a gain in power of 4-fold (i.e. equivalent to having a sample size 16 times larger), compared with the conventional approach. In contrast, highly significant changes are only detected at a cohort level using t-tests, restricting their potential use within personalized medicine and increasing the number of animals required during testing. Furthermore, LPM enabled the relative volumes of responding and non-responding tissue to be estimated for each xenograft model. Leave-one-out analysis of the treated xenografts provided quality control and identified potential outliers, raising confidence in LPM data at clinically relevant sample sizes. AVAILABILITY AND IMPLEMENTATION: TINA Vision open source software is available from www.tina-vision.net. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Oxford University Press 2018-08-01 2018-03-14 /pmc/articles/PMC6061877/ /pubmed/29547950 http://dx.doi.org/10.1093/bioinformatics/bty115 Text en © The Author(s) 2018. Published by Oxford University Press. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Papers
Tar, P D
Thacker, N A
Babur, M
Watson, Y
Cheung, S
Little, R A
Gieling, R G
Williams, K J
O’Connor, J P B
A new method for the high-precision assessment of tumor changes in response to treatment
title A new method for the high-precision assessment of tumor changes in response to treatment
title_full A new method for the high-precision assessment of tumor changes in response to treatment
title_fullStr A new method for the high-precision assessment of tumor changes in response to treatment
title_full_unstemmed A new method for the high-precision assessment of tumor changes in response to treatment
title_short A new method for the high-precision assessment of tumor changes in response to treatment
title_sort new method for the high-precision assessment of tumor changes in response to treatment
topic Original Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061877/
https://www.ncbi.nlm.nih.gov/pubmed/29547950
http://dx.doi.org/10.1093/bioinformatics/bty115
work_keys_str_mv AT tarpd anewmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment
AT thackerna anewmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment
AT baburm anewmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment
AT watsony anewmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment
AT cheungs anewmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment
AT littlera anewmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment
AT gielingrg anewmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment
AT williamskj anewmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment
AT oconnorjpb anewmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment
AT tarpd newmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment
AT thackerna newmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment
AT baburm newmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment
AT watsony newmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment
AT cheungs newmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment
AT littlera newmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment
AT gielingrg newmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment
AT williamskj newmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment
AT oconnorjpb newmethodforthehighprecisionassessmentoftumorchangesinresponsetotreatment